GlobeNewswire BiotechnologyQwen · 实盘不做把握 9/10不做原因:不是事件
北京时间·🕒 发布 20:00:00·⟳ 抓取 20:01:53·⚡ 决策 09-01 20:11:56 +10m03s·56.3 天前
Voyager Therapeutics宣布将参加9月多场投资者会议，属常规IR活动，无新增实质信息
该公告是标准的投资者会议参加通知（conference participation announcement），仅列出五场会议的日期、时间和地点，不含任何新增实质信息（无管线数据、无财务指引、无合作/授权进展、无监管动态）。此类公告是所有上市公司的常规IR活动，不构成任何方向性催化，无法产生交易edge。
📄 原文GlobeNewswire Biotechnology↗ 原文
Voyager to Present at Upcoming Investor Conferences
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company…
不做 Voyager Therapeutics（VYGR.US）
公告仅为常规投资者会议参加通知，不含任何新增管线数据、财务指引、合作进展或监管信息，不构成交易催化，无方向性edge
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Voyager Therapeutics于2026年9月1日发布GlobeNewswire通稿，宣布将参加9月8-15日间的五场投资者会议（Wells Fargo、Cantor、Morgan Stanley、Baird's、H.C. Wainwright）并做炉边对话。公告全文仅包含会议日程和公司简介，无任何新增数据、指引、合作或监管信息。投资者会议参加通知是最常规的IR活动之一，不改变公司基本面预期，不构成交易催化。结论：不做。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无：事件本身不构成催化，先例研究不适用
方向:不适用：常规会议参加通知无方向性，无需先例校准
涨幅量级:不适用
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 5,395 ms
{"result": "search_processed_events:agent query=`voyager therapeutics investor conference participation | vygr conference fireside chat september 2026`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 62.4/72 小时、2202 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent query 表达式没有召回候选，不能据此证明消息首发或不是重复；按当前事件继续正常研判。"}
原文全文
展开原文 · 2,338 字
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences:
Wells Fargo 21st Annual Healthcare Conference:
Fireside chat at 3:45 p.m. ET on Tuesday, September 8, 2026, in Boston, MA.
2026 Cantor Global Healthcare Conference:
Fireside chat at 8:35 a.m. ET on Friday, September 11, 2026, in New York, NY.
Morgan Stanley 24th Annual Global Healthcare Conference:
Fireside chat at 10:45 a.m. ET on Monday, September 14, 2026, in New York, NY.
Baird’s 2026 Global Healthcare Conference:
Fireside chat at 7:55 a.m. ET on Tuesday, September 15, 2026, in New York, NY.
H.C. Wainwright 28th Annual Global Investment Conference:
Fireside chat at 2:30 p.m. ET on Tuesday, September 15, 2026, in New York, NY.
A webcast of the Wells Fargo fireside chat will be available and may be accessed from the Investors section of Voyager’s website at
ir.voyagertherapeutics.com
. A replay of the webcast will be archived on the company’s website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit
http://www.voyagertherapeutics.com
.
Voyager Therapeutics
®
is a registered trademark, and TRACER™
and Voyager NeuroShuttle™ are trademarks, of Voyager Therapeutics, Inc.
Contacts
Company and Investors: Trista Morrison, NACD.DC,
tmorrison@vygr.com
Media: Lisa Guiterman,
voyagerpr@scientpr.com
Wells Fargo 21st Annual Healthcare Conference:
Fireside chat at 3:45 p.m. ET on Tuesday, September 8, 2026, in Boston, MA.
2026 Cantor Global Healthcare Conference:
Fireside chat at 8:35 a.m. ET on Friday, September 11, 2026, in New York, NY.
Morgan Stanley 24th Annual Global Healthcare Conference:
Fireside chat at 10:45 a.m. ET on Monday, September 14, 2026, in New York, NY.
Baird’s 2026 Global Healthcare Conference:
Fireside chat at 7:55 a.m. ET on Tuesday, September 15, 2026, in New York, NY.
H.C. Wainwright 28th Annual Global Investment Conference:
Fireside chat at 2:30 p.m. ET on Tuesday, September 15, 2026, in New York, NY.
A webcast of the Wells Fargo fireside chat will be available and may be accessed from the Investors section of Voyager’s website at
ir.voyagertherapeutics.com
. A replay of the webcast will be archived on the company’s website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit
http://www.voyagertherapeutics.com
.
Voyager Therapeutics
®
is a registered trademark, and TRACER™
and Voyager NeuroShuttle™ are trademarks, of Voyager Therapeutics, Inc.
Contacts
Company and Investors: Trista Morrison, NACD.DC,
tmorrison@vygr.com
Media: Lisa Guiterman,
voyagerpr@scientpr.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。